Physicians Realty Trust Future Growth
Future criteria checks 2/6
Physicians Realty Trust is forecast to grow earnings and revenue by 14.9% and 3.7% per annum respectively. EPS is expected to grow by 8% per annum. Return on equity is forecast to be 2.5% in 3 years.
Key information
14.9%
Earnings growth rate
8.0%
EPS growth rate
Health Care REITs earnings growth | 18.8% |
Revenue growth rate | 3.7% |
Future return on equity | 2.5% |
Analyst coverage | Low |
Last updated | 22 Feb 2024 |
Recent future growth updates
Recent updates
Healthpeak: A Qualitative Play For 2024E
Apr 01Physicians Realty Trust: A 7% REIT Gem With Merger-Related Growth Potential
Jan 08Physicians Realty Trust Offers A Solid Dividend And Exposure To Healthcare
Dec 29Physicians Realty Acquired By Healthpeak: Disgustingly Bad For Physicians Shareholders
Oct 30Physicians Realty Trust: 8% Yield, Oversold, Near 52-Week Lows
Oct 22Physicians Realty Trust: Juicy Income Now On Sale
Oct 09Physicians Realty Trust: A Case For M&A
Jul 31Physicians Realty Trust Is Much Safer Than It Looks
Jun 28Physicians Realty Trust Near 52-Week Low Is A Buy
May 26Physicians Realty Trust Q4 2022 Earnings Preview
Feb 21Better High-Yield Healthcare REIT Buy: Medical Properties Or Physicians Realty
Jan 11Physicians Realty Trust declares $0.23 dividend
Dec 22Physicians Realty Trust Q3 2022 Earnings Preview
Nov 02Physicians Realty Trust declares $0.23 dividend
Sep 23Physicians Realty Trust acquires Calko Medical Center for $81.5M
Sep 13Physicians Realty Trust: A Good Doctor Against Market Volatility
Sep 02Do Physicians Realty Trust's (NYSE:DOC) Earnings Warrant Your Attention?
Aug 01Physicians Realty Trust: Steady 5.4% Yield, With 14% Upside
Jun 23Physicians Realty Trust: Passive Income With A Safe 5.2% Yield
Apr 11Do Physicians Realty Trust's (NYSE:DOC) Earnings Warrant Your Attention?
Mar 30Physicians Realty Trust: Consistency In The Absence Of Growth
Mar 08Physicians Realty Trust: Solid Performance, Despite Lacking Diversity
Feb 23Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 562 | 76 | N/A | N/A | 2 |
12/31/2025 | 581 | 60 | N/A | N/A | 4 |
12/31/2024 | 563 | 54 | N/A | N/A | 1 |
12/31/2023 | 545 | 42 | 273 | 273 | N/A |
9/30/2023 | 540 | 47 | 262 | 262 | N/A |
6/30/2023 | 533 | 97 | 265 | 265 | N/A |
3/31/2023 | 530 | 101 | 268 | 268 | N/A |
12/31/2022 | 526 | 104 | 258 | 258 | N/A |
9/30/2022 | 509 | 120 | 273 | 273 | N/A |
6/30/2022 | 493 | 79 | 264 | 264 | N/A |
3/31/2022 | 473 | 80 | 260 | 260 | N/A |
12/31/2021 | 456 | 84 | 247 | 247 | N/A |
9/30/2021 | 451 | 74 | 243 | 243 | N/A |
6/30/2021 | 445 | 69 | 248 | 248 | N/A |
3/31/2021 | 442 | 68 | 240 | 240 | N/A |
12/31/2020 | 436 | 65 | 233 | 233 | N/A |
9/30/2020 | 433 | 88 | 227 | 227 | N/A |
6/30/2020 | 431 | 87 | 213 | 213 | N/A |
3/31/2020 | 417 | 77 | 210 | 210 | N/A |
12/31/2019 | 415 | 73 | 201 | 201 | N/A |
9/30/2019 | 413 | 43 | 203 | 203 | N/A |
6/30/2019 | 408 | 51 | 203 | 203 | N/A |
3/31/2019 | 420 | 55 | 194 | 194 | N/A |
12/31/2018 | 423 | 55 | 209 | 209 | N/A |
9/30/2018 | 413 | 54 | 198 | 198 | N/A |
6/30/2018 | 403 | 43 | 194 | 194 | N/A |
3/31/2018 | 372 | 42 | 187 | 187 | N/A |
12/31/2017 | 344 | 37 | 180 | 180 | N/A |
9/30/2017 | 318 | 36 | N/A | 166 | N/A |
6/30/2017 | 294 | 33 | N/A | 156 | N/A |
3/31/2017 | 271 | 30 | N/A | 141 | N/A |
12/31/2016 | 241 | 28 | N/A | 127 | N/A |
9/30/2016 | 207 | 25 | N/A | 109 | N/A |
6/30/2016 | 173 | 19 | N/A | 98 | N/A |
3/31/2016 | 149 | 16 | N/A | 72 | N/A |
12/31/2015 | 129 | 11 | N/A | 59 | N/A |
9/30/2015 | 109 | 7 | N/A | 48 | N/A |
6/30/2015 | 88 | 2 | N/A | 32 | N/A |
3/31/2015 | 70 | -1 | N/A | 23 | N/A |
12/31/2014 | 53 | -4 | N/A | 13 | N/A |
9/30/2014 | 40 | -6 | N/A | 9 | N/A |
6/30/2014 | 30 | -5 | N/A | 4 | N/A |
3/31/2014 | 21 | -4 | N/A | 0 | N/A |
12/31/2013 | 17 | -2 | N/A | 1 | N/A |
9/30/2013 | 14 | -2 | N/A | 1 | N/A |
6/30/2013 | 13 | -2 | N/A | 3 | N/A |
3/31/2013 | 13 | -3 | N/A | 3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DOC's forecast earnings growth (14.9% per year) is above the savings rate (2.3%).
Earnings vs Market: DOC's earnings (14.9% per year) are forecast to grow faster than the US market (13.3% per year).
High Growth Earnings: DOC's earnings are forecast to grow, but not significantly.
Revenue vs Market: DOC's revenue (3.7% per year) is forecast to grow slower than the US market (8.1% per year).
High Growth Revenue: DOC's revenue (3.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: DOC's Return on Equity is forecast to be low in 3 years time (2.5%).